Lv1
30 积分 2025-06-02 加入
Clinical application of intermittent fasting for weight loss: progress and future directions
2天前
已完结
Health-Related quality of life (HRQL) assessments in a 52-Week, Double-Blind, randomized, Placebo-Controlled phase 3 study of resmetirom (MGL-3196) in patients with metabolic dysfunction associated steatohepatitis (MASH) and fibrosis
5天前
已完结
皖公网安备34019202002308
